Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aolanti Weipang Tablets in functional dyspepsia
NCT03971383Phase 2Unknown
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Start
- Jun 2019
- Primary completion
- Oct 2020
- Countries
- 1
01
Overview
A Phase 2 trial of Aolanti Weikang in functional dyspepsia (FD), sponsored by Jiangxi Qingfeng Pharmaceutical Co. Ltd.. Status: unknown.
02
Drugs
Aolanti Weikang
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT03971383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03971383.